股票 › BCAX
Bicara 制药 BCAX
美股市值排名 #3592
$8.65 +$0.46 (+5.62%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $8.65 0.00%
开盘$8.32
昨收$8.19
当日区间$8.06 – $8.93
成交量1.01M
市值$572.40M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$59.95M-87.2% YoY
净利润-$55.44M-102.4% YoY
摊薄每股收益-$0.82-64.0% YoY
自由现金流-$44.27M-73.0% YoY
经营现金流-$44.21M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-41.0%
资产收益率-38.4%
投入资本回报率-43.1%
流动比率11.59
负债/资产比率8.5%
现金及投资$497.26M
总负债$0.00
净现金（净负债）$497.26M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $59.95M | $60.24M | $155.60M | $41.12M | $40.68M |
| 销售及管理费用 | $14.18M | $12.74M | $30.51M | $8.13M | $7.70M |
| -管理费用 | $14.18M | $12.74M | $30.51M | $8.13M | $7.70M |
| 研发费用 | $45.77M | $47.50M | $125.10M | $32.99M | $32.98M |
| 营业利润 | -$59.95M | -$60.24M | -$155.60M | -$41.12M | -$40.68M |
| 非经营性利息净收入（支出） | $4.58M | $4.08M | $17.87M | $3.79M | $4.39M |
| 非经营性利息收入 | $4.58M | $4.08M | $17.87M | $3.79M | $4.39M |
| 税前利润 | -$55.38M | -$56.16M | -$137.73M | -$37.33M | -$36.29M |
| 税费 | $61,000.00 | $52,000.00 | $217,000.00 | $53,000.00 | $40,000.00 |
| 净利润 | -$55.44M | -$56.21M | -$137.95M | -$37.39M | -$36.33M |
| 持续经营利润 | -$55.44M | -$56.21M | -$137.95M | -$37.39M | -$36.33M |
| 归属母公司净利润 | -$55.44M | -$56.21M | -$137.95M | -$37.39M | -$36.33M |
| 归属普通股股东净利润 | -$55.44M | -$56.21M | -$137.95M | -$37.39M | -$36.33M |
| 基本每股收益 | -$0.82 | -$0.93 | -$2.52 | -$0.68 | -$0.67 |
| 摊薄每股收益 | -$0.82 | -$0.93 | -$2.52 | -$0.68 | -$0.67 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $512.24M | $553.60M | $430.99M | $430.99M | $424.69M |
| 流动资产合计 | $503.82M | $544.92M | $422.05M | $422.05M | $297.37M |
| 现金及现金等价物与短期投资 | $497.26M | $539.75M | $414.80M | $414.80M | $290.17M |
| -现金及现金等价物 | $96.60M | $323.46M | $96.69M | $96.69M | $171.67M |
| -短期投资 | $400.66M | $216.29M | $318.12M | $318.12M | $118.49M |
| 其他流动资产 | $6.56M | $5.16M | $7.25M | $7.25M | $7.21M |
| 非流动资产合计 | $8.42M | $8.68M | $8.94M | $8.94M | $127.32M |
| 固定资产净值 | $1.51M | $1.77M | $2.03M | $2.03M | $2.10M |
| -固定资产原值 | $1.51M | $1.77M | $2.03M | $2.03M | $2.10M |
| 其他非流动资产 | $6.91M | $6.91M | $6.91M | $6.91M | $7.80M |
| 负债合计 | $43.48M | $39.64M | $29.54M | $29.54M | $21.91M |
| 流动负债合计 | $43.48M | $39.34M | $28.95M | $28.95M | $21.03M |
| 应付款 | $8.46M | $7.44M | $7.79M | $7.79M | $3.66M |
| -应付账款 | $8.46M | $7.44M | $7.79M | $7.79M | $3.66M |
| 一年内应计费用 | $29.80M | $28.85M | $15.00M | $15.00M | $12.28M |
| 短期债务及融资租赁负债 | $1.16M | $1.14M | $1.12M | $1.12M | $1.10M |
| -一年内到期融资租赁负债 | $1.16M | $1.14M | $1.12M | $1.12M | $1.10M |
| 非流动负债合计 | $0.00 | $301,000.00 | $593,000.00 | $593,000.00 | $880,000.00 |
| 长期债务及融资租赁负债 | $0.00 | $301,000.00 | $593,000.00 | $593,000.00 | $880,000.00 |
| -长期融资租赁负债 | $0.00 | $301,000.00 | $593,000.00 | $593,000.00 | $880,000.00 |
| 股东权益合计 | $468.77M | $513.96M | $401.45M | $401.45M | $402.78M |
| 股东权益 | $468.77M | $513.96M | $401.45M | $401.45M | $402.78M |
| 股本 | $8,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| -普通股 | $8,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $939.94M | $929.37M | $760.17M | $760.17M | $724.49M |
| 留存收益 | -$470.61M | -$415.18M | -$358.97M | -$358.97M | -$321.58M |
| 不影响留存收益的损益 | -$567,000.00 | -$243,000.00 | $243,000.00 | $243,000.00 | -$136,000.00 |
| 投资及预付款 | – | – | – | – | $117.42M |
| -长期股权投资 | – | – | – | – | $117.42M |
| 可转换优先证券 | – | – | – | – | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$44.21M | -$37.51M | -$106.83M | -$23.89M | -$29.25M |
| 持续经营经营活动现金流净额 | -$44.21M | -$37.51M | -$106.83M | -$23.89M | -$29.25M |
| 持续经营净利润 | -$55.44M | -$56.21M | -$137.95M | -$37.39M | -$36.33M |
| 折旧、折耗与摊销 | $44,000.00 | $44,000.00 | $105,000.00 | $43,000.00 | $24,000.00 |
| 其他非现金项目 | $277,000.00 | $273,000.00 | $895,000.00 | $297,000.00 | $249,000.00 |
| 营运资金变动 | $2.43M | $12.19M | $14.81M | $8.44M | $3.16M |
| -预付资产变动 | -$1.40M | $2.09M | $5.28M | $839,000.00 | -$301,000.00 |
| -应付账款及应计费用变动 | $4.11M | $10.37M | $10.46M | $7.90M | $3.78M |
| -其他流动负债变动 | -$277,000.00 | -$270,000.00 | -$932,000.00 | -$292,000.00 | -$317,000.00 |
| 投资活动现金流净额 | -$184.99M | $100.94M | -$318.45M | -$82.33M | -$236.12M |
| 持续经营投资活动现金流净额 | -$184.99M | $100.94M | -$318.45M | -$82.33M | -$236.12M |
| 固定资产购置及出售净额 | -$60,000.00 | -$60,000.00 | -$280,000.00 | -$238,000.00 | -$42,000.00 |
| 投资购置及出售净额 | -$184.93M | $101.00M | -$318.17M | -$82.09M | -$236.08M |
| 筹资活动现金流 | $2.33M | $163.35M | $32.26M | $31.23M | $436,000.00 |
| 持续经营筹资活动现金流净额 | $2.33M | $163.35M | $32.26M | $31.23M | $436,000.00 |
| 普通股发行净额 | $0.00 | $161.76M | $29.50M | $29.50M | $0.00 |
| 股票期权行使所得 | $2.33M | $1.58M | $2.76M | $1.73M | $436,000.00 |
| 期末现金余额 | $96.60M | $323.46M | $96.69M | $96.69M | $171.67M |
| 现金净变动 | -$226.86M | $226.78M | -$393.03M | -$74.99M | -$264.93M |
| 期初现金余额 | $323.46M | $96.69M | $489.71M | $171.67M | $436.61M |
| 自由现金流 | -$44.27M | -$37.57M | -$107.11M | -$24.12M | -$29.29M |
暂无评论——快来第一个聊聊 BCAX。
登录后参与讨论。